Farnaz Gaminchi, MD
MOHS-Micrographic Surgery · West Hills, CANPI 1457404840
Payments from drug & device makers
Across 155 payments — averaging $45.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acera Surgical, Inc.$3K
- Galderma Laboratories, L.p.$912
- Sanofi$744
- AbbVie$436
- Sun Pharmaceutical Industries Inc.$388
- Regeneron Healthcare Solutions, Inc.$322
- plus $2K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acera Surgical, Inc. | 2 | $2,588 |
| Galderma Laboratories, L.p. | 15 | $912 |
| Sanofi | 20 | $744 |
| AbbVie(2 entities) | 18 | $436 |
| Sun Pharmaceutical Industries Inc. | 16 | $388 |
| Regeneron Healthcare Solutions, Inc. | 12 | $322 |
| E.r. Squibb & Sons, L.L.C. | 9 | $214 |
| LEO Pharma Inc. | 5 | $200 |
| Amgen | 3 | $173 |
| Pfizer | 7 | $156 |
| Sanofi-aventis U.S. LLC | 5 | $115 |
| EPI Health, LLC | 5 | $112 |
| Incyte Corporation | 5 | $108 |
| Mayne Pharma Commercial LLC | 8 | $81 |
| Merz North America, Inc. | 3 | $66 |
| Novartis | 3 | $66 |
| Arcutis Biotherapeutics, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $58 |
| Encore Dermatology Inc. | 3 | $55 |
| Mimedx Group, Inc. | 2 | $34 |
| Journey Medical Corporation | 1 | $30 |
| Biofrontera Inc. | 1 | $25 |
| Revance Therapeutics, Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $19 |
| Sebela Pharmaceuticals Inc. | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$7,059 in reported general payments places this provider in the 75th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other mohs-micrographic surgery in West Hills
- Michael MortazieOrange$1.2M
- Thuzar ShinSacramento$353K
- Sarah ArronBurlingame$223K
- Christopher Crosbyla Mesa$211K
- Abel TorresLoma Linda$136K
- Robert ScheinbergOceanside$129K
- Sherry RotundaOceanside$99K
- Sumaira AasiStanford$66K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.